Eukaryote – Page 4

ASCO24: Nimbus Unveils Promising Early Data for Next-Generation HPK1 Blocker in IO Therapies

2 years ago talkbio0Tagged ASCO24, Blocker, Clinical Trials, immuno-oncology, Malignant Neoplasms, MAP4K1 gene, Next-Generation IO Therapies, Nimbus

ASCO24, Nimbus, Next-Generation IO Therapies, HPK1 Blocker, Early Data, Cancer Treatment, Immuno-Oncology, Clinical Trials.

Novo, Gates, and Wellcome Join Forces with $300 Million Initiative to Tackle Global Infectious Diseases

2 years ago talkbio0Tagged Collaboration, Communicable Diseases, development aspects, Global Health, Holdings, Melinda, Microbicides, pandemic preparedness, research, Resistance (Psychotherapeutic), Trust (Social Behavior), Wellcome

Novo Holdings, Bill & Melinda Gates Foundation, Wellcome Trust, infectious diseases, global health, pandemic preparedness, antimicrobial resistance, research and development, funding, collaboration.

Sarepta’s ELEVIDYS Gaining Ground Amidst Anticipation for Expanded Label Approval

2 years ago talkbio0Tagged Age, Child, Commission, ELEVIDYS, Labels (device)

ELEVIDYS, Age, Muscular Dystrophy, Duchenne, Sarepta, Labels (device), Child

Sarepta shares PhII data for next-gen exon skipping drug, but regulatory pathway is unclear

2 years ago talkbio0Tagged Approved, Commission, Grail, next-generation exon-skipping drug, Regulatory Pathway, Sarepta's gene therapy, United States Food and Drug Administration

Regulatory Pathway, Sarepta, next-generation exon-skipping drug, United States Food and Drug Administration, Approved, Muscular Dystrophy, Duchenne, gene therapy, Sarepta’s gene therapy